SCHEMBL13874337

SCHEMBL13874337

Cn1cc(Br)c(-c2ccc(C(F)(F)F)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.44
AHR P35869 1/20 0.42
MAPK14 Q16539 2/20 0.42
MAPK13 O15264 1/20 0.42
CSNK1D P48730 1/20 0.42
CSNK1E P49674 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
KCNH2 Q12809 1/20 0.41
KIF11 P52732 2/20 0.40
PTPN1 P18031 1/20 0.39
BRAF P15056 2/20 0.39
SRC P12931 1/20 0.39
KDR P35968 1/20 0.39
CHKA P35790 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
TDP2 O95551 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27656180 0.81 MAPK14 (0.46) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL1554588 0.81 CSNK1D (0.57) HTR2AMAPK14MAPK13CSNK1DCSNK1E
SCHEMBL9933095 0.79 SMN1; SMN2 (0.49) HTR2AAHRMAPK14MAPK13CSNK1D
SCHEMBL13481172 0.79 RAB9A (0.43) AHRMAPK14MAPK13CSNK1DCSNK1E
SCHEMBL4128565 0.79 MAPK13 (0.54) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL4309166 0.77 KEAP1 (0.47) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL15885797 0.77 BRAF (0.46) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL3922875 0.77 L3MBTL1 (0.48) HTR2AMAPK14MAPK13CSNK1DCSNK1E
SCHEMBL17295105 0.76 SMN1; SMN2 (0.49) MAPK14MAPK13CSNK1DCSNK1EMAPK12
SCHEMBL5463467 0.76 MAPK13 (0.73) MAPK14MAPK13CSNK1DCSNK1EMAPK12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed